Dupilumab, an investigational monoclonal antibody directed against interleukin-4 and interleukin-13, was effective for treatment of moderate to severe atopic dermatitis in adults, and higher doses...

Field of Interest: Dermatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness